Angiotensin converting enzyme inhibitor induced cough: Experience in Siriraj Hospital

Journal of the Medical Association of Thailand

Volumn 86, Issue 7, 2003, Pages 647-654

  Buranakitjaroen, Peera ^a   Phoojaroenchanachai, Meta ^a   Saravich, Surachai ^a   Sriussadaporn, Sutin ^a   Sangprasert, Pantip ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

ACE Inhibitor; Cough

Indexed keywords

CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; PERINDOPRIL; QUINAPRIL; RAMIPRIL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; IRRITATIVE COUGHING; MAJOR CLINICAL STUDY; MALE; NOCTURNAL COUGH; OUTPATIENT; PREVALENCE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEX DIFFERENCE; THAILAND;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CILAZAPRIL; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; ISOQUINOLINES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TETRAHYDROISOQUINOLINES;

EID: 0141590264     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Konstam MA, Rousseau MF, Kronenberg MW, et al. Effect of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation 1992; 86: 431-8.
2. Sharma S, Deitchman D, Eni JS, Gelperin K, Ilgenfritz JP, Blumenthal M. The hemodynamic effects of long-term ACE inhibition with fosinopril in patients with heart failure. Fosinopril Hemodynamic Study Group. Am J Ther 1999; 6: 181-9.
3. Ruggenenti P, Perna A, Gherardi G, et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999; 354: 359-64.
4. Maschio G, Alberti D, Janin G, et al. for the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. New Engl J Med 1996; 334: 939-45.
5. Shamiss A, Carroll J, Peleg E, Grossman E, Rosenthal T. The effect of enalapril with or without hydrochlorohiazide on insulin sensitivity and other metabolic abnormalities of hypertensive patients with NIDDM. Am J Hypertens 1995; 8: 276-81.
6. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-41.
7. The Heart Outcome Prevention Evaluation Study Investigators. Effect of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. New Engl J Med 2000; 342: 145-53.
8. Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353: 611-6.
9. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med 1992; 117: 234-42.
10. Woo KS, Chan TY. High prevalence of persistent cough with angiotensin-converting enzyme inhibitors in Chinese. Br J Pharmacol 1995; 40: 141-4.
11. Simon SR, Black HR, Moser M, Berland WE. Cough and ACE inhibitors. Arch Intern Med 1993; 153: 782.
12. Hansson L, Lindholm LH, Ekboom T, et al. for the STOP-Hypertension-2 study group. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354: 1751-6.
13. Inman WH, Rawson NS, Wilton LV, Pearce GL, Speirs CJ. Postmarketing surveillance of enalapril I. Results of prescription-event monitoring. BMJ 1988; 297: 826-9.
14. Huckell VF, Belanger LG, Karmirski M, Subramanian T, Cox AJ. Lisinopril in the treatment of hypertension: A Canadian postmarketing surveillance study. Clin Ther 1993; 15: 407-22.
15. Larochelle P, Haynes B, Maron N, Dugas S. A post-marketing surveillance evaluation of quinapril in 2742 Canadian hypertensive patients: The ACCEPT study. Accupril Canadian Clinical Evaluation and Patient Teaching. Clin Ther 1994; 16: 838-53.
16. Kaplan NM. The CARE Study: A postmarketing evaluation of ramipril in 11,100 patients. The Clinical Altace Real-World Efficacy (CARE) Investigators. Clin Ther 1996; 18: 658-70.
17. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. New Engl J Med 1986; 314: 1657-64.
18. Testa MA, Anderson RB, Nackley JF, Hollenberg NK, and the Quality-of-Life Hypertension Study Group. Quality of life and antihypertensive therapy in men: A comparison of captopril with enalapril. New Engl J Med 1993; 328: 907-13.
19. Cohn JN, Johnson G, Ziesche S, et al. A comparison of with enalapril and hydralazine-isosorbide dinitrate in the treatment of congestive heart failure. New Engl J Med 1991; 325: 303-10.
20. Yeo WW, MacLean D, Richardson PJ, Ramsey LE. Cough and enalapril: Assessment by spontaneous reporting and visual analogue scale under double-blind conditions. Br J Clin Pharmacol 1991; 31: 356-359.
21. Yeo WW, Ramsay LE. Persistent dry cough with enalapril: Incidence depends on method used. J Hum Hypertens 1990; 4: 517-20.
22. Fletcher AE, Palmer AJ, Bulpitt CJ. Cough with angiotensin converting enzyme inhibitors: How much of a problem? J Hypertens 1994; 12: S43-7.
23. Singh NP, Uppal M, Anuradha S, Agarwal A, Rizvi SN. Angiotensin converting enzyme inhibitors and cough-a north Indian study. J Assoc Phys India 1998; 46: 448-51.
24. Os I, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S. Female sex as an important determinant of lisinopril induced cough. Lancet 1992; 339: 372.
25. Efstraopoulos AD, Meikopoulos M, Voyaki S. Frequency of cough during therapy with ACE inhibitors in Greek hypertensives. J Hum Hypertens 1993; 7: 607-9.
26. Adigun AQ, Ajayi AA. Angiotensin converting enzyme inhibitor induced by cough in Nigerians. West Afr J Med 2001; 20: 46-7.
27. Yesil S, Yesil M, Bayata S, Postaci N. ACE inhibitors and cough. Angiology 1994; 45: 805-8.
28. Surata T, Arakawa K, Limura O, et al. Difference in the incidence of cough induced by angiotensin converting enzyme inhibitors; a comparative study using imidapril hydrochloride and enalapril maleate. Hypertens Res 1999; 22: 197-202.